MENU
+Compare
WST
Stock ticker: NYSE
AS OF
Nov 13, 04:59 PM (EDT)
Price
$266.63
Change
-$7.22 (-2.64%)
Capitalization
19.7B

WST West Pharmaceutical Services Forecast, Technical & Fundamental Analysis

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries... Show more

WST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for WST with price predictions
Nov 12, 2025

WST sees MACD Histogram just turned negative

WST saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 31, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 47 instances where the indicator turned negative. In of the 47 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for WST moved out of overbought territory on October 27, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on November 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on WST as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WST declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

WST broke above its upper Bollinger Band on October 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 56 cases where WST's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WST advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 264 cases where WST Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. WST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.456) is normal, around the industry mean (10.242). P/E Ratio (40.570) is within average values for comparable stocks, (158.743). Projected Growth (PEG Ratio) (3.460) is also within normal values, averaging (2.733). Dividend Yield (0.003) settles around the average of (0.016) among similar stocks. P/S Ratio (6.614) is also within normal values, averaging (111.072).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
WST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

WST is expected to report earnings to fall 6.12% to $1.84 per share on February 12

West Pharmaceutical Services WST Stock Earnings Reports
Q4'25
Est.
$1.84
Q3'25
Beat
by $0.27
Q2'25
Beat
by $0.33
Q1'25
Beat
by $0.22
Q4'24
Beat
by $0.10
The last earnings report on October 23 showed earnings per share of $1.96, beating the estimate of $1.69. With 125.08K shares outstanding, the current market capitalization sits at 19.70B.
A.I.Advisor
published Dividends

WST paid dividends on August 06, 2025

West Pharmaceutical Services WST Stock Dividends
А dividend of $0.21 per share was paid with a record date of August 06, 2025, and an ex-dividend date of July 30, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceuticals, biologics, vaccines and consumer healthcare products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
530 Herman O. West Drive
Phone
+1 610 594-2900
Employees
10600
Web
https://www.westpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SMOT36.230.23
+0.64%
VanEck Morningstar SMID Moat ETF
IPAC75.550.35
+0.47%
iShares Core MSCI Pacific ETF
AGZD22.500.08
+0.36%
WisdomTree Interest RtHdgUS Aggt Bd ETF
TEMP51.60N/A
N/A
JPMorgan Climate Change Solutions ETF
RSSY20.49-0.31
-1.50%
Return Stacked U.S. Stocks & Futures Yield ETF

WST and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, WST has been loosely correlated with STVN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if WST jumps, then STVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WST
1D Price
Change %
WST100%
-1.28%
STVN - WST
36%
Loosely correlated
-2.03%
QDEL - WST
33%
Loosely correlated
+3.20%
CAPN - WST
32%
Poorly correlated
N/A
IRMD - WST
30%
Poorly correlated
+2.11%
RGEN - WST
30%
Poorly correlated
+2.98%
More

Groups containing WST

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WST
1D Price
Change %
WST100%
-1.28%
Pharmaceuticals
category (378 stocks)
19%
Poorly correlated
-0.99%
Pharmaceuticals: Other
category (103 stocks)
18%
Poorly correlated
-1.40%